BioHealth News Archive
REGENXBIO Announces Positive Interim Data and Update for Phase I/II Trial of RGX-121 for the Treatment of MPS II | BioSpace
ROCKVILLE, Md., Dec. 8, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of…
Read More
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors | Novavax Inc. – IR Site
GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today…
Read More
Vaccitech, Future Planet backed Oxford Spinout, Offers Global Path to End of COVID-19 — Future Planet Capital
This week, interim Phase III data was released for the Oxford / AstraZeneca Vaccine, co-invented by our portfolio company Vaccitech. From late December, assuming…
Read More
Novo Holdings: the world’s largest biotech investor | Sifted
What’s the world’s largest charitable foundation? Nope, its not the Bill and Melinda Gates Foundation. Not even the Wellcome Trust. It’s Novo Nordisk Foundation,…
Read More
AUTM 2021 Conference
Top Reasons to Attend: The world may have stopped, but your professional development doesn't have to. Education and networking from the comfort of your…
Read More2020: The Human Immunome: Small Moves Become a Movement — The Golden Goose Award
The Human Immunome: Small Moves Become a Movement “We’re basic scientists. We did not set out initially just to make drugs. That’s not what…
Read More
COVID-19 — The Disease That Is Reshaping Manufacturing | NIST
Unless you’ve been living on private island (send invite immediately!), it’s no secret that the pandemic has changed the way manufacturers operate and run…
Read More
Avoid these 5 real-world data pitfalls when planning your patient registry, cohort study, or observational clinical study
When clinical investigators and study coordinators start planning a new study design, speed and efficiency are paramount. Running a clinical study takes careful planning.…
Read More
Reflecting on 2020 and Wishing You Happy Holidays
Though it began like any other year, 2020 has proven to be one of the most difficult and frustrating periods of our lifetime. This…
Read More
United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Dec. 9, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that the United States…
Read More
George Washington University, US Patent Innovations targeting cancer and Covid in $3.2M corporate research agreement – Washington Business Journal
The university licenses its original patent to the company to develop the product and conduct early-stage clinical trials. Image: Michael Keidar, a mechanical engineer…
Read More
The Enactment of Bayh-Dole, An Inside Perspective – IPWatchdog.com | Patents & Patent Law
We caught the tide– but just barely. That the Bayh-Dole Act passed was amazing. That it passed in a lame duck session of Congress…
Read More
Where In The World Should I Conduct My Pivotal Clinical Trial? · BioBuzz
The COVID pandemic has certainly forced us to re-think the whole paradigm of conducting clinical trials. From design, site and CRO selection, patient recruitment,…
Read More
Emmes Announces its Contribution to Second Remdesivir Clinical Trial for COVID-19 | BioSpace
ROCKVILLE, Md., Dec. 14, 2020 /PRNewswire/ -- Emmes today announced that it has conducted the data and statistical analysis for the second iteration of the…
Read More
AstraZeneca to acquire Alexion for $39 billion in blockbuster deal
AstraZeneca on Saturday said it was acquiring Alexion Pharmaceuticals for $39 billion, marking a significant expansion into the treatment of rare diseases of the…
Read More